Jefferies Group’s Rocket Pharmaceuticals RCKT Stock Holding History

Jefferies Group’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$359K	Buy	+22,500	New	+$351K	﹤0.01%	1163
2021 Q4	–	Sell	-1	Closed	-$30	–	1933
2021 Q3	$30	Buy	+1	New	+$36	﹤0.01%	1677
2021 Q1	–	Sell	-35,000	Closed	-$1.92M	–	1925
2020 Q4	$1.92M	Buy	+35,000	New	+$1.28M	0.02%	726
2020 Q1	–	Sell	-48,277	Closed	-$1.1M	–	2562
2019 Q4	$1.1M	Buy	+48,277	New	+$806K	0.01%	1412

Other funds holding RCKT

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jefferies Group's RCKT Position: Q3 2022 in Review

Jefferies Group opened a new position in Rocket Pharmaceuticals (RCKT) in Q3 2022: 22,500 shares worth $359K. The stake represents ﹤0.01% of the portfolio and ranks #1163 among its holdings. This is a return to the name: Jefferies Group previously reported a position in RCKT as recently as Q3 2021.

Jefferies Group first reported a position in RCKT in Q4 2019 and has held it in 4 quarters since. The position peaked at $1.92M in Q4 2020. 164 funds tracked by Wall St. Rank hold RCKT as of Q3 2022.

Jefferies Group held 22,500 shares of Rocket Pharmaceuticals worth $359K as of Q3 2022.
Rocket Pharmaceuticals was a new Jefferies Group position in Q3 2022.
Rocket Pharmaceuticals made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1163 holding.
Jefferies Group first reported a position in Rocket Pharmaceuticals in Q4 2019 and has held it in 4 quarters since.
Jefferies Group's Rocket Pharmaceuticals position peaked at $1.92M in Q4 2020.
164 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.